Advanced in Osteitis Fibrosa

Dr. Betsy Palal

Endocrinology
Thyroid & Diabetes Specialists Of Las Vegas Nakhle M.D. PLLC
9280 W Sunset Rd Ste 306, 
Las Vegas, NV 

Advanced in Osteitis Fibrosa
Thyroid & Diabetes Specialists Of Las Vegas Nakhle M.D. PLLC
9280 W Sunset Rd Ste 306, 
Las Vegas, NV 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Betsy Palal is an Endocrinologist in Las Vegas, Nevada. Dr. Palal is rated as an Advanced provider by MediFind in the treatment of Osteitis Fibrosa. Her top areas of expertise are Hypothyroidism, Type 2 Diabetes (T2D), Parathyroid Hyperplasia, and Neonatal Severe Hyperparathyroidism.

Her clinical research consists of co-authoring 1 peer reviewed article and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in NV
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
EMI Health
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Golden Rule
  • INSURANCE PLAN
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Moda Health
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
SelectHealth
  • HMO
  • POS
Silversummit Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 28 Less Insurance Carriers -

Locations

Thyroid & Diabetes Specialists of Las Vegas Nakhle M.D. PLLC
9280 W Sunset Rd Ste 306, Las Vegas, NV 89148
Call: 702-696-7256
Other Locations
Palm Medical Group Nakhle MD PLLC
3150 N Tenaya Way Ste 415, Las Vegas, NV 89128
Call: 702-696-7256

Additional Areas of Focus

Dr. Palal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Study of LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring
A Study of LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug
Study Drugs: LY900014, Insulin Glargine
Study Phase: Phase 3
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
Enrollment Status: Completed
Publish Date: October 27, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: January 19, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
Enrollment Status: Completed
Publish Date: March 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

1 Total Publications

Life-Threatening Hypocalcemia following Subtotal Parathyroidectomy in a Patient with Renal Failure and Previous Roux-en-Y Gastric Bypass Surgery.
Life-Threatening Hypocalcemia following Subtotal Parathyroidectomy in a Patient with Renal Failure and Previous Roux-en-Y Gastric Bypass Surgery.
Journal: Case reports in endocrinology
Published: January 01, 2011
Similar Doctors
Advanced in Osteitis Fibrosa
Dr. Samer Nakhle
Endocrinology
Advanced in Osteitis Fibrosa
Dr. Samer Nakhle
Endocrinology

Palm Medical Group

9280 W Sunset Rd Ste 306, 
Las Vegas, NV 
 (0.6 miles away)
Languages Spoken:
English
See accepted insurances

Samer Nakhle is an Endocrinologist in Las Vegas, Nevada. Dr. Nakhle is rated as a Distinguished provider by MediFind in the treatment of Osteitis Fibrosa. His top areas of expertise are Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, Medullary Thyroid Carcinoma, and Thyroid Cancer.

Advanced in Osteitis Fibrosa
Dr. Quang Nguyen
Endocrinology
Advanced in Osteitis Fibrosa
Dr. Quang Nguyen
Endocrinology

Woodson Dermatology

229 N Pecos Rd Ste 100, 
Henderson, NV 
 (12.2 miles away)
702-605-5750
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Quang Nguyen is an Endocrinologist in Henderson, Nevada. Dr. Nguyen is rated as a Distinguished provider by MediFind in the treatment of Osteitis Fibrosa. His top areas of expertise are Hashimoto Thyroiditis, Type 2 Diabetes (T2D), Obesity in Children, and Vitamin D Deficiency.

Advanced in Osteitis Fibrosa
Dr. Molouk Rahnema
Endocrinology
Advanced in Osteitis Fibrosa
Dr. Molouk Rahnema
Endocrinology

Molok Rahnema MD Valley Endocrinology PLLC

653 N Town Center Dr Ste 504, 
Las Vegas, NV 
 (7.5 miles away)
702-701-8400
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Molouk Rahnema is an Endocrinologist in Las Vegas, Nevada. Dr. Rahnema is rated as a Distinguished provider by MediFind in the treatment of Osteitis Fibrosa. Her top areas of expertise are Diabetic Nephropathy, Type 2 Diabetes (T2D), Hypothyroidism, and Graves Disease.

VIEW MORE OSTEITIS FIBROSA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Palal's expertise for a condition
ConditionClose
      • Advanced
      • Familial Isolated Hyperparathyroidism
        Dr. Palal is
        Advanced
        . Learn about Familial Isolated Hyperparathyroidism.
        See more Familial Isolated Hyperparathyroidism experts
      • Hyperparathyroidism
        Dr. Palal is
        Advanced
        . Learn about Hyperparathyroidism.
        See more Hyperparathyroidism experts
      • Hyperthyroidism
        Dr. Palal is
        Advanced
        . Learn about Hyperthyroidism.
        See more Hyperthyroidism experts
      • Hypothyroidism
        Dr. Palal is
        Advanced
        . Learn about Hypothyroidism.
        See more Hypothyroidism experts
      • Maturity Onset Diabetes of the Young
        Dr. Palal is
        Advanced
        . Learn about Maturity Onset Diabetes of the Young.
        See more Maturity Onset Diabetes of the Young experts
      • Neonatal Severe Hyperparathyroidism
        Dr. Palal is
        Advanced
        . Learn about Neonatal Severe Hyperparathyroidism.
        See more Neonatal Severe Hyperparathyroidism experts
      View All 12 Advanced Conditions
      • Experienced
      • Adrenal Gland Adenoma
        Dr. Palal is
        Experienced
        . Learn about Adrenal Gland Adenoma.
        See more Adrenal Gland Adenoma experts
      • Anaplastic Thyroid Cancer
        Dr. Palal is
        Experienced
        . Learn about Anaplastic Thyroid Cancer.
        See more Anaplastic Thyroid Cancer experts
      • Diabetes Insipidus (DI)
        Dr. Palal is
        Experienced
        . Learn about Diabetes Insipidus (DI).
        See more Diabetes Insipidus (DI) experts
      • Empty Sella Syndrome
        Dr. Palal is
        Experienced
        . Learn about Empty Sella Syndrome.
        See more Empty Sella Syndrome experts
      • Eunuchoidism Familial Hypogonadotropic
        Dr. Palal is
        Experienced
        . Learn about Eunuchoidism Familial Hypogonadotropic.
        See more Eunuchoidism Familial Hypogonadotropic experts
      • Familial Glucocorticoid Deficiency
        Dr. Palal is
        Experienced
        . Learn about Familial Glucocorticoid Deficiency.
        See more Familial Glucocorticoid Deficiency experts
      View All 40 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.